AstraZeneca launches 1st at-home flu vaccine

(By: Alexandra Murphy for Becker’s Hospital Review)

AstraZeneca has issued its flu vaccine nasal spray for at-home use.

The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 news release from the drugmaker. FluMist was initially approved by the FDA in 2003 and is the first seasonal influenza vaccine authorized for at-home use, the company said. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.